Yuto Yasuda

573 total citations
35 papers, 346 citations indexed

About

Yuto Yasuda is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Yuto Yasuda has authored 35 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 16 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Yuto Yasuda's work include Lung Cancer Treatments and Mutations (12 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Lung Cancer Research Studies (5 papers). Yuto Yasuda is often cited by papers focused on Lung Cancer Treatments and Mutations (12 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Lung Cancer Research Studies (5 papers). Yuto Yasuda collaborates with scholars based in Japan, Canada and United States. Yuto Yasuda's co-authors include Hironori Yoshida, Hiroaki Ozasa, Takashi Nomizo, Takahiro Tsuji, Yuichi Sakamori, Tomoko Funazo, Toyohiro Hirai, Young Hak Kim, Hiroki Nagai and Yasushi Yoshimura and has published in prestigious journals such as Nature Communications, Cancer Research and Scientific Reports.

In The Last Decade

Yuto Yasuda

34 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuto Yasuda Japan 10 221 172 121 62 59 35 346
Takashi Nomizo Japan 11 236 1.1× 175 1.0× 124 1.0× 64 1.0× 57 1.0× 28 354
Tomoko Funazo Japan 10 223 1.0× 172 1.0× 123 1.0× 62 1.0× 56 0.9× 28 347
Hidenori Kitai Japan 8 150 0.7× 89 0.5× 232 1.9× 52 0.8× 48 0.8× 16 330
Mark P. Roberto United States 4 112 0.5× 110 0.6× 100 0.8× 54 0.9× 61 1.0× 4 285
Heather A. Hirsch United States 9 235 1.1× 69 0.4× 234 1.9× 39 0.6× 76 1.3× 19 420
Carolien Boeckx Belgium 12 225 1.0× 109 0.6× 155 1.3× 99 1.6× 38 0.6× 15 374
Carmen G. Rea Italy 7 207 0.9× 143 0.8× 92 0.8× 69 1.1× 20 0.3× 15 322
Jodi A. McKenzie United States 8 121 0.5× 73 0.4× 155 1.3× 54 0.9× 81 1.4× 30 302
Jie‐Hua He China 10 214 1.0× 83 0.5× 199 1.6× 47 0.8× 16 0.3× 11 390
Rico D. Bense Netherlands 8 298 1.3× 166 1.0× 177 1.5× 141 2.3× 153 2.6× 9 508

Countries citing papers authored by Yuto Yasuda

Since Specialization
Citations

This map shows the geographic impact of Yuto Yasuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuto Yasuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuto Yasuda more than expected).

Fields of papers citing papers by Yuto Yasuda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuto Yasuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuto Yasuda. The network helps show where Yuto Yasuda may publish in the future.

Co-authorship network of co-authors of Yuto Yasuda

This figure shows the co-authorship network connecting the top 25 collaborators of Yuto Yasuda. A scholar is included among the top collaborators of Yuto Yasuda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuto Yasuda. Yuto Yasuda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yasuda, Yuto, Geoffrey N. Maksym, Lu Wang, Pasquale Chitano, & Chun Y. Seow. (2024). Characteristics of lung resistance and elastance associated with tracheal stenosis and intrapulmonary airway narrowing in ex vivo sheep lungs. Respiratory Research. 25(1). 332–332. 1 indexed citations
2.
Yasuda, Yuto, Lu Wang, Pasquale Chitano, & Chun Y. Seow. (2024). Rho-Kinase Inhibition of Active Force and Passive Tension in Airway Smooth Muscle: A Strategy for Treating Airway Hyperresponsiveness in Asthma. Biology. 13(2). 115–115. 3 indexed citations
3.
Yasuda, Yuto, Lu Wang, Pasquale Chitano, & Chun Y. Seow. (2023). Critical roles of airway smooth muscle in mediating deep-inspiration-induced bronchodilation: a big stretch?. Respiratory Research. 24(1). 250–250. 1 indexed citations
4.
Yasuda, Yuto, et al.. (2022). Efficacy of the combination of baricitinib, remdesivir, and dexamethasone in hypoxic adults with COVID-19: A retrospective study. Respiratory Medicine and Research. 81. 100903–100903. 4 indexed citations
5.
Yasuda, Yuto, Junko Tanizaki, Yoshikane Nonagase, et al.. (2022). The safety and efficacy of durvalumab consolidation therapy in the management of patients with stage III non-small-cell lung cancer and preexisting interstitial lung disease. Respiratory Investigation. 60(5). 667–673. 6 indexed citations
6.
Yasuda, Yuto, et al.. (2022). Aluminium Gauze Reduces SARS-CoV-2 Viral Load in Non-Woven Masks Worn by Patients with COVID-19. Infectious Disease Reports. 14(2). 250–257. 2 indexed citations
7.
Funazo, Tomoko, Takahiro Tsuji, Hiroaki Ozasa, et al.. (2020). Acquired Resistance to Alectinib in ALK-Rearranged Lung Cancer due to ABCC11/MRP8 Overexpression in a Clinically Paired Resistance Model. Molecular Cancer Therapeutics. 19(6). 1320–1327. 5 indexed citations
8.
Yasuda, Yuto, Hiroaki Ozasa, Young Hak Kim, et al.. (2020). MCL1 inhibition is effective against a subset of small-cell lung cancer with high MCL1 and low BCL-XL expression. Cell Death and Disease. 11(3). 177–177. 32 indexed citations
9.
Tsuji, Takahiro, Hiroaki Ozasa, Wataru Aoki, et al.. (2020). YAP1 mediates survival of ALK-rearranged lung cancer cells treated with alectinib via pro-apoptotic protein regulation. Nature Communications. 11(1). 74–74. 57 indexed citations
10.
Yoshida, Hironori, Takashi Nomizo, Hiroaki Ozasa, et al.. (2020). PD-L1 polymorphisms predict survival outcomes in advanced non-small-cell lung cancer patients treated with PD-1 blockade. European Journal of Cancer. 144. 317–325. 13 indexed citations
11.
Funazo, Tomoko, Takashi Nomizo, Hiroaki Ozasa, et al.. (2019). Clinical impact of low serum free T4 in patients with non-small cell lung cancer treated with nivolumab. Scientific Reports. 9(1). 17085–17085. 13 indexed citations
12.
Tsuji, Takahiro, Hiroaki Ozasa, Wataru Aoki, et al.. (2018). Alectinib Resistance in ALK-Rearranged Lung Cancer by Dual Salvage Signaling in a Clinically Paired Resistance Model. Molecular Cancer Research. 17(1). 212–224. 41 indexed citations
13.
Yoshida, Hironori, Young Hak Kim, Hiroaki Ozasa, et al.. (2018). Efficacy of Ceritinib After Alectinib for ALK-positive Non-small Cell Lung Cancer. In Vivo. 32(6). 1587–1590. 7 indexed citations
14.
Yasuda, Yuto, Takashi Nomizo, Hiroaki Ozasa, et al.. (2017). Retrospective analysis of acute exacerbation of interstitial lung diseases with nanoparticle albumin-bound paclitaxel in patients with advanced lung cancer with preexisting interstitial lung disease. Molecular and Clinical Oncology. 7(4). 677–680. 9 indexed citations
15.
Nomizo, Takashi, Hiroaki Ozasa, Takahiro Tsuji, et al.. (2017). Clinical Impact of Single Nucleotide Polymorphism in PD-L1 on Response to Nivolumab for Advanced Non-Small-Cell Lung Cancer Patients. Scientific Reports. 7(1). 45124–45124. 69 indexed citations
16.
Yoshida, Hironori, Young Hak Kim, Hiroaki Ozasa, et al.. (2017). EGFR T790M Detection in Circulating Tumor DNA from Non-small Cell Lung Cancer Patients Using the PNA-LNA Clamp Method. Anticancer Research. 37(5). 2721–2725. 10 indexed citations
17.
Yoshida, Hironori, Hiroaki Ozasa, Hiroki Nagai, et al.. (2017). Nivolumab in non-small-cell lung cancer with EGFR mutation. Annals of Oncology. 29(3). 777–778. 29 indexed citations
18.
Ozasa, Hiroaki, Susumu Satô, Yuichi Sakamori, et al.. (2016). Survival impact of treatment for chronic obstructive pulmonary disease in patients with advanced non-small cell lung cancer. Annals of Oncology. 27. vi460–vi460. 2 indexed citations
19.
Okamori, Satoshi, Eisaku Tanaka, Yuto Yasuda, et al.. (2015). Nontuberculous mycobacterial infection in chronic obstructive pulmonary disease. PA569–PA569. 1 indexed citations
20.
Matsumoto, Hikaru, et al.. (1996). [Flow cytometric analysis of the DNA content of resected non-small cell lung cancer with reference to long-term follow-up].. PubMed. 23 Suppl 2. 130–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takashi Nomizo Breakdown of academic impact, for papers by Tomoko Funazo Breakdown of academic impact, for papers by Hidenori Kitai Breakdown of academic impact, for papers by Mark P. Roberto Breakdown of academic impact, for papers by Heather A. Hirsch Breakdown of academic impact, for papers by Carolien Boeckx Breakdown of academic impact, for papers by Carmen G. Rea Breakdown of academic impact, for papers by Jodi A. McKenzie Breakdown of academic impact, for papers by Jie‐Hua He Breakdown of academic impact, for papers by Rico D. Bense
Rankless by CCL
2026